Creative Biolabs-Immuno-oncology

Anti-ITGAL (clone chMHM2E4I) SynExpress pU-Cy3-I10-E Modified CD8+ T cells (CAT#: ITS-1224-CR142)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target ITGAL (clone chMHM2E4I). We employs the Lentivirus (pUC-Cy3-IL-10-EcoRI) vector components and the SynExpress system of the Exons Insertion/Positive feedback for a robust and sustained response against cancers.
Host
Chimeric
Target
ITGAL
Clone
chMHM2E4I
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
pUC
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Insertion
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.99
Cell Culture
Microcarrier Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving